vaccines
DomesticBiological Product
Recombinant Human Tumor Necrosis Factor-α ReceptorⅡ:IgG Fc Fusion Protein for Injection
海正生物制药有限公司
Drug Information
| Generic name | 注射用重组人II型肿瘤坏死因子受体-抗体融合蛋白 |
|---|---|
| English name | Recombinant Human Tumor Necrosis Factor-α ReceptorⅡ:IgG Fc Fusion Protein for Injection |
| Dosage form | Injection |
| Specification | 25mg/瓶,生物学活性为2.50×10^6AU/瓶 |
| Category | Biological Product |
| Approval no. | 国药准字S20150006 |
| Drug code | 86904641003188 |
| Manufacturer | 海正生物制药有限公司 |
| Production address | 浙江省杭州市富阳区胥口镇海正路8号 |
| Origin | Domestic |
| Approval date | 2019-12-19 |
Source: NMPA (National Medical Products Administration) drug registration data, for reference only. This page does not include dosage or indications; follow your doctor's advice and read the package insert.